-       Report 
   - March 2025
    -  175 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - March 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - March 2025
    -  175 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - February 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - February 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                 -       Report 
   - February 2025
    -  200 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                -       Report 
   - January 2025
    -  175 Pages 
    Global
   
   From       €4036EUR$4,490USD£3,539GBP 
                  -       Report 
   - September 2025
    -  147 Pages 
    Global
   
   From       €2291EUR$2,549USD£2,009GBP 
      €2696EUR$2,999USD£2,364GBP 
                  -       Drug Pipelines 
   - April 2025
    -  80 Pages 
    Global
   
   From       €1438EUR$1,600USD£1,261GBP 
      €1798EUR$2,000USD£1,577GBP 
                -       Report 
   - May 2025
    -  114 Pages 
    Global
   
   From       €4269EUR$4,750USD£3,744GBP 
                  -       Report 
   - August 2025
    -  147 Pages 
    Global
   
   From       €3550EUR$3,950USD£3,114GBP 
                -       Report 
   - June 2025
    -  400 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Report 
   - June 2025
    -  400 Pages 
    Global
   
   From       €4448EUR$4,949USD£3,901GBP 
                -       Report 
   - August 2025
    -  88 Pages 
    Global
   
   From       €3500EUR$4,171USD£3,177GBP 
                -       Report 
   - September 2025
    -  150 Pages 
    Global
   
   From       €3460EUR$3,850USD£3,035GBP 
                -       Report 
   - April 2025
    -  59 Pages 
    Global
   
   From       €2652EUR$2,950USD£2,325GBP 
                -       Report 
   - December 2024
    -  151 Pages 
    Middle East, Africa
   
   From       €3101EUR$3,450USD£2,720GBP 
                -       Report 
   - August 2019
    -  264 Pages 
    Global
   
   From       €3591EUR$3,995USD£3,149GBP 
                -       Report 
   - August 2022
    -  121 Pages 
    Global
   
   From       €1168EUR$1,299USD£1,024GBP 
                -       Report 
   - January 2022
    -  151 Pages 
    Global
   
   From       €4313EUR$4,799USD£3,783GBP 
             
         Genome Editing is a technology used to make precise changes to the DNA of living organisms. It is used in a variety of applications, including gene therapy, crop engineering, and basic research. Genome Editing is a rapidly growing field within the genomics industry, as it allows for the manipulation of genetic material with unprecedented accuracy and speed.
Genome Editing is typically done using a variety of tools, such as CRISPR-Cas9, TALENs, and ZFNs. These tools allow for the insertion,    deletion, or modification of specific DNA sequences. This technology has enabled researchers to make targeted changes to the genome of living organisms, allowing for the development of new treatments and therapies.
The Genome Editing market is expected to continue to grow in the coming years, as the technology is increasingly used in a variety of applications. Companies in the market include Editas Medicine, CRISPR Therapeutics, Intellia Therapeutics, Caribou Biosciences, and Sangamo Therapeutics. Show Less   Read more